Q2 2023 Holdings
Filed 2023-08-02 | 22 holdings | $322.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Protagonist Therapeutics Inc.(PTGX) | COM | 74366E102 | $67.6M | 2,449,183 | 21.0% |
| Legend Biotech Corporation(LEGN) | ADS | 52490G102 | $56.2M | 814,586 | 17.5% |
| CVRx, Inc.(CVRX) | COM | 126638105 | $54.0M | 3,495,575 | 16.8% |
| MeiraGTx Holdings plc(MGTX) | COM | G59665102 | $44.6M | 6,641,064 | 13.9% |
| Xencor, Inc.(XNCR) | COM | 98401F105 | $18.7M | 748,062 | 5.8% |
| Fusion Pharmaceuticals Inc. | COM | 36118A100 | $17.1M | 3,670,516 | 5.3% |
| Fate Therapeutics, Inc.(FATE) | COM | 31189P102 | $16.1M | 3,379,064 | 5.0% |
| Procept BioRobotics Corporation(PRCT) | COM | 74276L105 | $12.7M | 357,939 | 3.9% |
| Point Biopharma Global Inc. | COM | 730541109 | $9.1M | 1,000,000 | 2.8% |
| Arrowhead Pharmaceuticals, Inc.(ARWR) | COM | 04280A100 | $8.8M | 247,598 | 2.7% |
| Nano-X Imaging Ltd.(NNOX) | ORD SHS | M70700105 | $4.9M | 317,704 | 1.5% |
| Vor Biopharma, Inc. | COM | 929033108 | $3.3M | 1,074,658 | 1.0% |
| Aldeyra Therapeutics, Inc.(ALDX) | COM | 01438T106 | $3.3M | 394,834 | 1.0% |
| Cue Health, Inc.(HLTHQ) | COM | 229790100 | $2.0M | 5,548,864 | 0.6% |
| Adicet Bio, Inc.(TORCEUR) | COM | 007002108 | $1.8M | 728,944 | 0.6% |
| BiomX Inc. | COM | 09090D103 | $768.0K | 2,133,402 | 0.2% |
| SomaLogic, Inc.(SLGCUSD) | COM | 83444K105 | $649.2K | 281,052 | 0.2% |
| Clearside Biomedical, Inc.(CLSDUSD) | COM | 185063104 | $190.0K | 169,629 | 0.1% |
| Apollomics, Inc. | CL A SHS | G0411D107 | $75.9K | 13,252 | 0.0% |
| Senseonics Holdings, Inc.(SENS1GBP) | COM | 81727U105 | $41.7K | 54,621 | 0.0% |
| Tracon Pharmaceuticals, Inc. | COM | 89237H209 | $24.4K | 84,003 | 0.0% |
| Catalyst Biosciences, Inc. | COM | 14888D208 | $23.5K | 66,951 | 0.0% |